[go: up one dir, main page]

AR060049A1 - MODULATING COMPOUNDS OF THE S1P RECEIVER AND USE OF THE SAME - Google Patents

MODULATING COMPOUNDS OF THE S1P RECEIVER AND USE OF THE SAME

Info

Publication number
AR060049A1
AR060049A1 ARP070101165A ARP070101165A AR060049A1 AR 060049 A1 AR060049 A1 AR 060049A1 AR P070101165 A ARP070101165 A AR P070101165A AR P070101165 A ARP070101165 A AR P070101165A AR 060049 A1 AR060049 A1 AR 060049A1
Authority
AR
Argentina
Prior art keywords
alkyl
halogen
alkoxy
group
substituted
Prior art date
Application number
ARP070101165A
Other languages
Spanish (es)
Inventor
Ashis Saha
Xiang Y Yu
Mercedes Lobera
Jian Lin
Srinivasa R Cheruku
Yael Marantz
Nili Schutz
Roland Burli
Oren M Becker
Original Assignee
Epix Delaware Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/491,766 external-priority patent/US7855193B2/en
Application filed by Epix Delaware Inc filed Critical Epix Delaware Inc
Publication of AR060049A1 publication Critical patent/AR060049A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicacion 1: Un compuesto caracterizado porque responde a la formula (1) en donde A es un grupo arilo o heteroarilo opcionalmente sustituido; B y C son un sistema de anillos bicíclico al menos parcialmente aromático; X se selecciona en el grupo que consiste de WC(O)OR6a, WP(O)R6bR6c, WS(O)2OH, WCONHSO3H o 1H-tetrazol-5-ilo; cuando W es un enlace directo, oxígeno o alquilo C1-4 con uno o más sustituyentes seleccionados en forma independiente entre el grupo que consiste de grupos halogeno, hidroxilo, ciano, amino, alquilamino, arilamino, heteroarilamino, alcoxi C1-4 y COO2H; R6a es hidrogeno o alquilo C1-4; y R6b y R6c son en forma independiente hidrogeno, hidroxilo, alquilo C1-4 o alquilo C1-4 sustituido con halogeno; Y es un residuo de formula (2) donde los asteriscos izquierdo y derecho indican el punto de union, en donde Q se selecciona entre el grupo que consiste de enlace directo, C=O, C=S, SO2, C=ONR o (CR10R11)m; m es 0, 1, 2 o 3; R7 y R8 se seleccionan en forma independiente entre el grupo que consiste de hidrogeno, halogeno, amino, alquil C1-5amino, hidroxilo, ciano, alquilo C1-6, hidroxialquilo C1-6 (por ejemplo, alquilo terminado con hidroxi), alquiltio C1-5, alcoxi C1-5, alquilo C1-6 sustituido con halogeno y alcoxi C1-5 sustituido con halogeno; o R7 y R8 pueden unirse con los átomos a los cuales están unidos para formar un anillo de 4 a 7 miembros, que tiene opcionalmente un heteroátomo; y R9 se selecciona entre el grupo que consiste de hidrogeno, halogeno, hidroxilo, ciano, alquilo C1-6, alquiltio C1-5, alcoxi C1-5, alquilo C1-6 sustituido con halogeno o alcoxi C1-5 sustituido con halogeno; R10 y R11 se seleccionan en forma independiente entre el grupo que consiste de hidrogeno, halogeno, hidroxilo, ciano, alquilo C1-6, alcoxi C1-5, alquiltio C1-5, alquilo C1-6 sustituido con halogeno o alcoxi C1-5 sustituido con halogeno; y Z1 y Z2 se seleccionan en forma independiente entre el grupo que consiste de O, NR3, S, S(O), S(O)2, S(O)2NR3, (CR4R5)n, C=O, C=S, C=N-R3, o un enlace directo, donde R3 se selecciona entre el grupo que consiste de hidrogeno, hidroxilo, SO2, C=O, C=S, C=NH, alquilo C1-6, alcoxi C1-5, alquiltio C1-5, alquilo C1-6 sustituido con halogeno y alcoxi C1-5 sustituido con halogeno; arilo o heteroarilo, o cuando Z2 es un enlace directo, R3 es un anillo de C3-6 que contiene opcionalmente un heteroátomo; R4 y R5 se seleccionan en forma independiente entre el grupo que consiste de hidrogeno, halogeno, hidroxilo, ciano, alquilo C1-6, alcoxi C1-5, alquiltio C1-5, alquilo C1-6 sustituido con halogeno y alcoxi C1-5 sustituido con halogeno; arilo o heteroarilo o formar juntos C=O; y n es 0, 1, 2 o 3; y R1 se selecciona entre el grupo que consiste de alquilo C1-6, alquenilo C2-6, alquinilo C2-6, cicloalquilo C3-6, alcoxi C1-5, alquil C1-5amino, arilo o heteroarilo.Claim 1: A compound characterized in that it responds to formula (1) wherein A is an optionally substituted aryl or heteroaryl group; B and C are an at least partially aromatic bicyclic ring system; X is selected from the group consisting of WC (O) OR6a, WP (O) R6bR6c, WS (O) 2OH, WCONHSO3H or 1H-tetrazol-5-yl; when W is a direct bond, oxygen or C1-4 alkyl with one or more substituents independently selected from the group consisting of halogen, hydroxyl, cyano, amino, alkylamino, arylamino, heteroarylamino, C1-4 alkoxy and COO2H groups; R6a is hydrogen or C1-4 alkyl; and R6b and R6c are independently hydrogen, hydroxyl, C1-4 alkyl or C1-4 alkyl substituted with halogen; Y is a residue of formula (2) where the left and right asterisks indicate the junction point, where Q is selected from the group consisting of direct bond, C = O, C = S, SO2, C = ONR or ( CR10R11) m; m is 0, 1, 2 or 3; R7 and R8 are independently selected from the group consisting of hydrogen, halogen, amino, C1-5 alkyl, hydroxy, cyano, C1-6 alkyl, hydroxy C1-6 alkyl (eg, hydroxy terminated alkyl), C1 alkylthio -5, C1-5 alkoxy, C1-6 alkyl substituted with halogen and C1-5 alkoxy substituted with halogen; or R7 and R8 can bind to the atoms to which they are attached to form a 4- to 7-membered ring, which optionally has a heteroatom; and R9 is selected from the group consisting of hydrogen, halogen, hydroxyl, cyano, C1-6 alkyl, C1-5 alkylthio, C1-5 alkoxy, halogen substituted C1-6 alkyl or halogen substituted C1-5 alkoxy; R10 and R11 are independently selected from the group consisting of hydrogen, halogen, hydroxyl, cyano, C1-6 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-6 alkyl substituted with halogen or C1-5 alkoxy substituted with halogen; and Z1 and Z2 are independently selected from the group consisting of O, NR3, S, S (O), S (O) 2, S (O) 2NR3, (CR4R5) n, C = O, C = S , C = N-R3, or a direct bond, where R3 is selected from the group consisting of hydrogen, hydroxyl, SO2, C = O, C = S, C = NH, C1-6 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-6 alkyl substituted by halogen and C1-5 alkoxy substituted by halogen; aryl or heteroaryl, or when Z2 is a direct bond, R3 is a C3-6 ring optionally containing a heteroatom; R4 and R5 are independently selected from the group consisting of hydrogen, halogen, hydroxyl, cyano, C1-6 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-6 alkyl substituted with halogen and C1-5 alkoxy substituted with halogen; aryl or heteroaryl or together form C = O; and n is 0, 1, 2 or 3; and R1 is selected from the group consisting of C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl, C1-5 alkoxy, C1-5amino alkyl, aryl or heteroaryl.

ARP070101165A 2006-03-21 2007-03-21 MODULATING COMPOUNDS OF THE S1P RECEIVER AND USE OF THE SAME AR060049A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78454906P 2006-03-21 2006-03-21
US11/491,766 US7855193B2 (en) 2005-11-23 2006-07-24 S1P receptor modulating compounds and use thereof

Publications (1)

Publication Number Publication Date
AR060049A1 true AR060049A1 (en) 2008-05-21

Family

ID=39456287

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070101165A AR060049A1 (en) 2006-03-21 2007-03-21 MODULATING COMPOUNDS OF THE S1P RECEIVER AND USE OF THE SAME

Country Status (2)

Country Link
AR (1) AR060049A1 (en)
PE (1) PE20080248A1 (en)

Also Published As

Publication number Publication date
PE20080248A1 (en) 2008-04-10

Similar Documents

Publication Publication Date Title
AR060050A1 (en) MODULATING COMPOUNDS OF THE S1P RECEIVER AND USE OF THE SAME
PE20121282A1 (en) SPIRO-OXINDOL ANTAGONISTS OF MDM2
CO6231035A2 (en) NOVEDOUS HETEROMONOCICLIC COMPOUND THAT HAS SUPERIOR PROPERTIES AS A PHARMACEUTICAL AGENT
NZ777370A (en) Bicyclic derivatives
ES2452299T3 (en) Heterocyclic Fungicidal Compounds
AR057987A1 (en) CB1 AGONIST COMPOUNDS (CANNABINOID RECEPTOR)
AR049388A1 (en) HETEROCICLES AS INHIBITORS OF ALDOSTERONA SINTASA
CO6220949A2 (en) PIRAZOLIC DERIVATIVES AS INHIBITORS OF THE 11 BETA -HSD1
BRPI0922366B8 (en) compound, pharmaceutical composition and use of a compound
MX2021007540A (en) Bicyclic derivatives.
AR076810A1 (en) ANTI-BANERIGEN COMPOUNDS OF AMINO PYRIMIDINE
BR112017021803A2 (en) bicyclic quinazolinone derivatives
HN2008000179A (en) TRICYCLE COMPOUNDS, COMPOSITIONS AND PROCEDURES
MX2015010775A (en) Substituted benzoxazoles and methods of use thereof.
MX2015014861A (en) C-linked heterocycloalkyl substituted pyrimidines and their uses.
CY1111628T1 (en) Substituted bicyclactam compounds
MX392211B (en) 5-FLUORO-4-IMINO-3-(ALKYL/SUBSTITUTED ALKYL)-1-(ARYLSULFONYL)-3,4-DIHYDROPYRIMIDIN-2(1<i>H</i>)-ONE AND PROCESSES FOR THEIR PREPARATION
AR061923A1 (en) COMPOUNDS DERIVED FROM BENZOFURAN-PIPERIDINA
AR074435A1 (en) DERIVATIVES OF 1,3-BENZOTIAZOL, DRUGS THAT CONTAIN THEM AND USE OF THE SAME IN THE TREATMENT OF CANCER.
AR088449A1 (en) BENZILINDAZOLES REPLACED
AR058404A1 (en) DIAMINE DERIVATIVES AS INHIBITORS OF LEUCOTRENE A4 HIDROLASA
EA201071234A1 (en) IZOHINOLINON DERIVATIVES AS NK3 ANTAGONISTS
TW200732295A (en) Selective N-sulfonylation of 2-amino trifluoroalkyl substituted alcohols
ES2528441T3 (en) Hetarylaminonaphthyridines
AR078270A1 (en) JAK INHIBITORS (JANUS QUINASAS)

Legal Events

Date Code Title Description
FB Suspension of granting procedure